We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ARLINGTON, Va., Dec. 1 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, The Market Outlook for Research Products in FY2010. The 8.2 billion dollars appropriated to...
ORANGE COUNTY, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate...
By Jon Kamp Of DOW JONES NEWSWIRES The medical-devices sector's trade organization asked Senate Finance Chairman Max Baucus on Monday to drop a proposed $4 billion annual fee for the industry as...
Improves Full Year Earnings Outlook ORANGE COUNTY, Calif., July 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer and marketer of products that...
CHICAGO, March 26 /PRNewswire/ -- "Options News," hosted by Carrie Long and http://www.onn.tv/ Chief Investment Strategist Jud Pyle, reviews futures and overseas trading, discusses the latest...
Johns Hopkins Report Represents Major Step in Cancer Genome Research FULLERTON, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Agencourt Bioscience Corporation, a Beckman Coulter company, announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.8 | -4.7197640118 | 16.95 | 17.05 | 16 | 3707 | 16.49064422 | DE |
4 | 0.2 | 1.2539184953 | 15.95 | 17.15 | 15.7 | 3586 | 16.55172221 | DE |
12 | -0.05 | -0.308641975309 | 16.2 | 18.4 | 15.3 | 8930 | 16.43526232 | DE |
26 | -0.1 | -0.615384615385 | 16.25 | 18.4 | 14.2 | 6277 | 15.94635517 | DE |
52 | -2.6 | -13.8666666667 | 18.75 | 18.8 | 14.2 | 4993 | 16.18577158 | DE |
156 | 2.2 | 15.770609319 | 13.95 | 19.8 | 10.25 | 3717 | 15.10495952 | DE |
260 | 2.25 | 16.1870503597 | 13.9 | 19.8 | 7.4 | 4913 | 12.982281 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions